Cost savings of red cell salvage during cesarean delivery

Obstetrics and Gynecology

Volumn 124, Issue 4, 2014, Pages 690-696

  Albright, Catherine M ^a   Rouse, Dwight J ^a   Werner, Erika F ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD SALVAGE; CESAREAN SECTION; CONTROLLED STUDY; COST CONTROL; ERYTHROCYTE TRANSFUSION; FEMALE; HUMAN; INTRAOPERATIVE RED CELL SALVAGE; MAJOR CLINICAL STUDY; MONTE CARLO METHOD; PRIORITY JOURNAL; RISK FACTOR; ADULT; BLOOD AUTOTRANSFUSION; COHORT ANALYSIS; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; ECONOMICS; FOLLOW UP; PEROPERATIVE CARE; PREGNANCY; PROCEDURES; RISK ASSESSMENT; TREATMENT OUTCOME;

ADULT; BLOOD TRANSFUSION, AUTOLOGOUS; CESAREAN SECTION; COHORT STUDIES; COST SAVINGS; COST-BENEFIT ANALYSIS; ERYTHROCYTE TRANSFUSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTRAOPERATIVE CARE; MONTE CARLO METHOD; OPERATIVE BLOOD SALVAGE; PREGNANCY; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 84925226918     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0000000000000465     Document Type: Article

References (65)

1. The 2011 national blood collection and utilization survey report. U.S. Department of Health and Human Services; Available at: http://www.hhs.gov/ash/bloodsafety/2011-nbcus.pdf. Retrieved June 20, 2014.
2. Carless PA, Henry DA, Moxey AJ, O'Connell D, Brown T, Fergusson DA. Cell salvage for minimising perioperative allogeneic blood transfusion. The Cochrane Database of Systematic Reviews 2010, Issue 4. Art. No.: CD001888. DOI:10.1002/14651858.CD001888.pub4.
3. Davies L, Brown TJ, Haynes S, Payne K, Elliott RA, McCollum C. Cost-effectiveness of cell salvage and alternative methods of minimising perioperative allogeneic blood transfusion: a systematic review and economic model. Health Technol Assess 2006;10:iii-iv, ix-x, 1-210.
4. Ashworth A, Klein AA. Cell salvage as part of a blood conservation strategy in anaesthesia. Br J Anaesth 2010;105: 401-16.
5. Liumbruno GM, Meschini A, Liumbruno C, Rafanelli D. The introduction of intra-operative cell salvage in obstetric clinical practice: a review of the available evidence. Eur J Obstet Gynecol Reprod Biol 2011;159:19-25.
6. Liumbruno GM, Liumbruno C, Rafanelli D. Intraoperative cell salvage in obstetrics: is it a real therapeutic option? Transfusion 2011;51:2244-56.
7. Waters JH, Biscotti C, Potter PS, Phillipson E. Amniotic fluid removal during cell salvage in the cesarean section patient. Anesthesiology 2000;92:1531-6.
8. Sullivan I, Faulds J, Ralph C. Contamination of salvaged maternal blood by amniotic fluid and fetal red cells during elective Caesarean section. Br J Anaesth 2008;101:225-9.
9. Catling SJ, Williams S, Fielding AM. Cell salvage in obstetrics: an evaluation of the ability of cell salvage combined with leucocyte depletion filtration to remove amniotic fluid from operative blood loss at caesarean section. Int J Obstet Anesth 1999;8:79-84.
10. Blood transfusion safety. World Health Organization; 2006. Available at: http://www.who.int/bloodsafety/en/Blood-Transfusion-Safety.pdf. Retrieved November 20, 2013.
11. Fong J, Gurewitsch ED, Kang HJ, Kump L, Mack PF. An analysis of transfusion practice and the role of intraoperative red blood cell salvage during cesarean delivery. Anesth Analg 2007;104:666-72.
12. Rainaldi MP, Tazzari PL, Scagliarini G, Borghi B, Conte R. Blood salvage during caesarean section. Br J Anaesth 1998; 80:195-8.
13. Rebarber A, Lonser R, Jackson S, Copel JA, Sipes S. The safety of intraoperative autologous blood collection and autotransfusion during cesarean section. Am J Obstet Gynecol 1998;179: 715-20.
14. King M, Wrench I, Galimberti A, Spray R. Introduction of cell salvage to a large obstetric unit: the first six months. Int J Obstet Anesth 2009;18:111-7.
15. Parry N, Junghans C, Skelton V, Okunuga A. Audit of cell salvage use in obstetric patients: adding experience. Int J Obstet Anesth 2010;19:238-9.
16. McDonnell NJ, Kennedy D, Long LJ, Gallagher-Swann MC, Paech MJ. The development and implementation of an obstetric cell salvage service. Anaesth Intensive Care 2010; 38:492-9.
17. Sullivan JV, Crouch ME, Stocken G, Lindow SW. Blood cell salvage during cesarean delivery. Int J Gynaecol Obstet 2011; 115:161-3.
18. Slonim AD, Bish EK, Xie RS. Red blood cell transfusion safety: probabilistic risk assessment and cost/benefits of risk reduction strategies. Ann Oper Res 1-30 [epub ahead of print 12 July, 2011].
19. Zalpuri S, Zwaginga JJ, le Cessie S, Elshuis J, Schonewille H, van der Bom JG. Red-blood-cell alloimmunization and number of red-blood-cell transfusions. Vox Sang 2012;102:144-9.
20. Hawk AF, Chang EY, Shields SM, Simpson KN. Costs and clinical outcomes of noninvasive fetal RhD typing for targeted prophylaxis. Obstet Gynecol 2013;122:579-85.
21. Keeling MM, Gray LA Jr, Brink MA, Hillerich VK, Bland KI. Intraoperative autotransfusion. Experience in 725 consecutive cases. Ann Surg 1983;197:536-41.
22. Grimes DA. A simplified device for intraoperative autotransfusion. Obstet Gynecol 1988;72:947-50.
23. Jackson SH, Lonser RE. Safety and effectiveness of intracesarean blood salvage. Transfusion 1993;33:181.
24. Potter PS, Waters JH, Burger GA, Mraovic B. Application of cell-salvage during cesarean section. Anesthesiology 1999;90: 619-21.
25. Oei S, Wingen C, Kerkkamp H. Cell salvage: how safe in obstetrics? Int J Obstet Anesth 2000;9:143.
26. Catling SJ, Freites O, Krishnan S, Gibbs R. Clinical experience with cell salvage in obstetrics: 4 cases from one UK centre. Int J Obstet Anesth 2002;11:128-34.
27. de Souza A, Permezel M, Anderson M, Ross A, McMillan J, Walker S. Antenatal erythropoietin and intra-operative cell salvage in a Jehovah's Witness with placenta praevia. BJOG 2003; 110:524-6.
28. Waters JH, Lukauskiene E, Anderson ME. Intraoperative blood salvage during cesarean delivery in a patient with beta thalassemia intermedia. Anesth Analg 2003;97:1808-9.
29. Malik S, Brooks H, Singhal T. Cell saver use in obstetrics. J Obstet Gynaecol 2010;30:826-8.
30. Ralph CJ, Sullivan I, Faulds J. Intraoperative cell salvaged blood as part of a blood conservation strategy in Caesarean section: is fetal red cell contamination important? Br J Anaesth 2011;107:404-8.
31. Tevet A, Grisaru-Granovsky S, Samueloff A, Ioscovich A. Peripartum use of cell salvage: a university practice audit and literature review. Arch Gynecol Obstet 2012;285:281-4.
32. Elagamy A, Abdelaziz A, Ellaithy M. The use of cell salvage in women undergoing cesarean hysterectomy for abnormal placentation. Int J Obstet Anesth 2013;22:289-93.
33. Catling S, Joels L. Cell salvage in obstetrics: the time has come. BJOG 2005;112:131-2.
34. Catling S. Blood conservation techniques in obstetrics: a UK perspective. Int J Obstet Anesth 2007;16:241-9.
35. Allam J, Cox M, Yentis SM. Cell salvage in obstetrics. Int J Obstet Anesth 2008;17:37-45.
36. Geoghegan J, Daniels JP, Moore PAS, Thompson PJ, Khan KS, Gülmezoglu AM. Cell salvage at caesarean section: the need for an evidence-based approach. BJOG 2009;116:743-7.
37. Waters JR, Meier HH, Waters JH. An economic analysis of costs associated with development of a cell salvage program. Anesth Analg 2007;104:869-75.
38. Rouse DJ, MacPherson C, Landon M, Varner MW, Leveno KJ, Moawad AH, et al. Blood transfusion and cesarean delivery. Obstet Gynecol 2006;108:891-7.
39. Esper SA, Waters JH. Intra-operative cell salvage: a fresh look at the indications and contraindications. Blood Transfus 2011;9: 139-47.
40. Waters JH, Dyga RM, Yazer MH, editors; American Association of Blood Banks. Guidelines for blood recovery and reinfusion in surgery and trauma. Bethesda (MD): AABB; 2010:29.
41. Frank SM. Who benefits from red blood cell salvage?-Utility and value of intraoperative autologous transfusion. Transfusion 2011;51:2058-60.
42. Jacobs RJ, Saab S, Meyerhoff AS. The cost effectiveness of hepatitis immunization for US college students. J Am Coll Health 2003;51:227-36.
43. Birkmeyer JD, AuBuchon JP, Littenberg B, O'Connor GT, Nease RF Jr, Nugent WC, et al. Cost-effectiveness of preoperative autologous donation in coronary artery bypass grafting. Ann Thorac Surg 1994;57:161-8.
44. Centers for Disease Control and Prevention. DVH-Division of Viral Hepatitis. Available at: http://www.cdc.gov/hepatitis/.Retrieved January 30, 2014.
45. Gerlach JT, Diepolder HM, Zachoval R, Gruener NH, Jung MC, Ulsenheimer A, et al. Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance. Gastroenterology 2003;125:80-8.
46. Kamal SM. Acute hepatitis C: a systematic review. Am J Gastroenterol 2008;103:1283-97.
47. Ghany MG, Strader DB, Thomas DL, Seeff LB; American Association for the Study of Liver Diseases. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 2009;49:1335-74.
48. AIDSinfo. Information on HIV/AIDS Treatment, Prevention and Research. Available at: http://aidsinfo.nih.gov/. Retrieved January 30, 2014.
49. Zalpuri S, Middelburg RA, Schonewille H, de Vooght KMK, le Cessie S, van der Bom JG, et al. Intensive red blood cell transfusions and risk of alloimmunization. Transfusion 2014; 54:278-84.
50. Blood types. American Red Cross. Available at: http://www.redcrossblood.org/. Retrieved November 20, 2013.
51. Crémieux PY, Barrett B, Anderson K, Slavin MB. Cost of outpatient blood transfusion in cancer patients. J Clin Oncol 2000; 18:2755-61.
52. Shander A, Hofmann A, Ozawa S, Theusinger OM, Gombotz H, Spahn DR. Activity-based costs of blood transfusions in surgical patients at four hospitals. Transfusion 2010; 50:753-65.
53. Rein DB, Smith BD, Wittenborn JS, Lesesne SB, Wagner LD, Roblin DW, et al. The cost-effectiveness of birth-cohort screening for hepatitis C antibody in U.S. primary care settings. Ann Intern Med 2012;156:263-70.
54. Owusu-Edusei K Jr, Chesson HW, Gift TL, Tao G, Mahajan R, Ocfemia MCB, et al. The estimated direct medical cost of selected sexually transmitted infections in the United States, 2008. Sex Transm Dis 2013;40:197-201.
55. Razavi H, Elkhoury AC, Elbasha E, Estes C, Pasini K, Poynard T, et al. Chronic hepatitis C virus (HCV) disease burden and cost in the United States. Hepatology 2013;57: 2164-70.
56. Juusola JL, Brandeau ML, Long EF, Owens DK, Bendavid E. The cost-effectiveness of symptom-based testing and routine screening for acute HIV infection in men who have sex with men in the USA. AIDS 2011;25:1779-87.
57. Schackman BR, Gebo KA, Walensky RP, Losina E, Muccio T, Sax PE, et al. The lifetime cost of current human immunodeficiency virus care in the United States. Med Care 2006;44: 990-7.
58. Hutchinson AB, Farnham PG, Dean HD, Ekwueme DU, del Rio C, Kamimoto L, et al. The economic burden of HIV in the United States in the era of highly active antiretroviral therapy: evidence of continuing racial and ethnic differences. J Acquir Immune Defic Syndr 2006;43:451-7.
59. Farnham PG, Gopalappa C, Sansom SL, Hutchinson AB, Brooks JT, Weidle PJ, et al. Updates of lifetime costs of care and quality-of-life estimates for HIV-infected persons in the United States: late versus early diagnosis and entry into care. J Acquir Immune Defic Syndr 2013;64:183-9.
60. Pilgrim H, Lloyd-Jones M, Rees A. Routine antenatal anti-D prophylaxis for RhD-negative women: a systematic review and economic evaluation. Health Technol Assess 2009;13:iii, ix-xi, 1-103.
61. Dasta JF, McLaughlin TP, Mody SH, Piech CT. Daily cost of an intensive care unit day: the contribution of mechanical ventilation. Crit Care Med 2005;33:1266-71.
62. Oh J. Average cost per inpatient day across 50 states in 2010. Becker's Hospital Review. 2012. Available at: http://www.beckershospitalreview.com/lists/average-cost-per-inpatient-day-across-50-states-in-2010.html. Retrieved December 10, 2013.
63. Hospital adjusted expenses per inpatient day. Available at: http://kff.org/other/state-indicator/expenses-per-inpatient-day/. Retrieved December 10, 2013.
64. Eller A, Porter T, Soisson P, Silver R. Optimal management strategies for placenta accreta. BJOG 2009;116:648-54.
65. Fitzpatrick KE, Sellers S, Spark P, Kurinczuk JJ, Brocklehurst P, Knight M. The management and outcomes of placenta accreta, increta, and percreta in the UK: a population-based descriptive study. BJOG 2014;121:62-70.